How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pa...

all societies face the need to make judgments about what interventions (both public health and personal medical) to provide to their populations under reasonable resource constraints. their decisions should be informed by good evidence and arguments from health technology assessment (hta). but if hta restricts itself to evaluations of safety, efficacy, and cost-effectiveness, it risks being vie...

background: various decisions have been made on technology application at all levels of the health system in different countries around the world. health technology assessment is considered as one of the best scientific tools at the service of policy- makers. this study attempts to investigate the current challenges of iran’s health technology assessment and provide appropriate strategies to es...

All societies face the need to make judgments about what interventions (both public health and personal medical) to provide to their populations under reasonable resource constraints. Their decisions should be informed by good evidence and arguments from health technology assessment (HTA). But if HTA restricts itself to evaluations of safety, efficacy, and cost-effectiveness, it risks being vie...

 To understand the role of health technology assessment (HTA) as a means of relating research with healthcare decision making.  To familiarize participants with the most important definitions related to HTA.  To recognize the main features of Economic Evaluations (EE).  To identify the usefulness and necessity of EE in the decision making process.  To understand the concept of opportunity ...

All societies face the need to make judgments about what interventions (both public health and personal medical) to provide to their populations under reasonable resource constraints. Their decisions should be informed by good evidence and arguments from health technology assessment (HTA). But if HTA restricts itself to evaluations of safety, efficacy, and cost-effectiveness, it risks being vie...

Recommendation by the High Level Pharmaceutical Forum (2008): national authorities and companies to be engaged in early dialogues with the aim of improving the generation of appropriate data for products in development (Recommendation 6). First Early Dialogue Initiatives: ‘single HTA’ advice (since 2009) and parallel regulatory HTA advice organized by the EMA with a limited number of HTA bodies...

INTRODUCTION Health Technology Assessment (HTA) plays a key role in the policy and decision-making process. Nevertheless, it is time- and resource-consuming, and therefore requires proper resource allocation. Priority setting, as a best way to organize effective and explicit resource allocation systems, may be applied even in this field. OBJECTIVE The aim of this study was to provide an overv...

OBJECTIVES Although ethics has been on the agenda in health technology assessment (HTA) since its inception, the integration of moral issues is still not standard and is performed in a vast variety of ways. Therefore, there is a need for a procedure for integrating moral issues in HTA. METHODS Literature review of existing approaches together with application of various theories in moral phil...

OBJECTIVES Health Technology Assessment (HTA) needs to address the challenges posed by high cost, effective technologies, expedited regulatory approaches, and the opportunities provided by collaborative real-world evaluation of technologies. The Health Technology Assessment International (HTAi) Policy Forum met to consider these issues and the implications for evidence production to inform HTA....